US FDA Funds Study To Learn Whether Kratom Users Have ‘Any Risk/Safety Considerations’

Agency says study “intended as a strategic response to understand and characterize emergent risk/safety and perceived benefits reportedly linked to kratom and psychedelics.” Objectives include understanding temporal relationships and correlation of purchase decisions and how marketing strategies nudge purchase and affect use demand.

• Source: Shutterstock

The US Food and Drug Administration continues its consideration of whether kratom should be lawful as a dietary ingredient by commissioning an exploratory study of consumers’ decisions about how, where and why they buy products containing the botanical.

In a notice published on 1 August announcing a sole source contract for market research firm Brightfield Group, the...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Archive

More from HBW Insight